Data coverage, completeness and provenance for ADALTA LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T04:50:18. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0020 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0035 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/1AD/prices · Price parameters and adjustment semantics
AdAlta Limited, a clinical-stage biotechnology company, develops cellular immunotherapies for the treatment of solid cancers in Australia. The company also commercializes protein therapeutics. In addition, it engages in the development of AD-21, a protein therapeutic for fibrotic diseases, including lung fibrosis and kidney fibrosis in Phase 1 clinical studies; and WD-34, a discovery stage i-body for the treatment and prevention of malaria and related diseases. The company was incorporated in 2006 and is based in Hawthorn East, Australia.
Employees: 2 · Website: https://www.adalta.com.au · Profile fields populated: 75%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/1AD/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 21 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 24 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 26 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 25 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 9 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/1AD
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/1AD/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/1AD/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/1AD/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/1AD/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/1AD
Free tier — instant API key. Built for AI agents.